Robot Stocks: Time to Separate the Winners... "Focus on Recurring Order Leaders" [Click eJongmok]

Robotics Sector Sees 19% Revenue Growth in Q2

Eugene Investment & Securities: "Overweight on the Sector"

With the second quarter 2026 earnings announcements from major domestic robotics companies now concluded, Eugene Investment & Securities maintained its "Overweight" investment rating on the robotics sector on August 19. The firm cited accelerating top-line growth centering on key players as the reason. No individual price targets were provided for specific stocks.

Rainbow Robotics' 'Hubo' series. Rainbow Robotics

Seungyoon Yang, an analyst at Eugene Investment & Securities, stated, "While expectations for the robotics industry are spreading throughout the stock market, market attention will increasingly differentiate in the future, focusing on companies that not only inspire expectation but also demonstrate business performance through sales growth, improved profitability, and recurring orders." The combined second-quarter revenue of domestic robotics companies increased by 19% compared to the same period last year.

By company, a clear shift in growth leadership was observed. Rainbow Robotics, a collaborative robot (cobot) manufacturer, posted second-quarter revenue of 12.3 billion won, up 98% year-on-year. However, its operating loss persisted at 2 billion won. For the first half, sales of mobile humanoids accounted for 8.65 billion won, representing 41% of the total, while revenue from Samsung Electronics stood at 5.7 billion won, or 27%. At the end of the second quarter, the company had 230 employees, an increase of 69 from the end of last year, and research and development was focused on actuator technology for humanoids (the driving mechanism that moves robotic joints). Analyst Yang assessed, "On the back of an expanded workforce and increased R&D investment, the company is quietly entering a full-fledged phase of performance growth."

Robotics component supplier ROBOTIS achieved both top-line and bottom-line growth. Second-quarter revenue came to 15.37 billion won, up 95%, and operating profit surged 723% to 1.98 billion won. Its key actuator business recorded sales of 15.1 billion won and operating profit of 3.4 billion won, resulting in an operating margin of 23%. Overseas sales increased by 118%, with balanced growth across major regions: China up 154%, North America 142%, and Europe 129%. Analyst Yang highlighted the impressive growth in the fiercely competitive Chinese market. As for inventory assets, which rose from 11.4 billion won to 18.3 billion won, and raw materials, which increased from 7 billion won to 11.7 billion won, he interpreted this as proactive inventory buildup in preparation for expanded production in the second half of the year.

Robot inspection and logistics automation company CEMES was noted for undergoing a fundamental business transformation. First-half revenue reached 9.52 billion won, up 101%, and gross profit was 1.92 billion won, a 95% increase. The company's first-half gross profit already surpassed last year's annual gross profit of 1.75 billion won. This year's cumulative new orders stand at 19.7 billion won, and the order backlog is 22.5 billion won, both up 2.4 times compared to last year. By segment, logistics reached 10.59 billion won, manufacturing 8.33 billion won, and inspection 3.63 billion won, demonstrating balanced expansion. Analyst Yang positively viewed the business model transformation, noting that "the shift is not just toward pilot adoption or one-off projects, but toward recurring orders from the same clients."

Surgical robotics company Curexo turned profitable. In the second quarter, sales of medical robots doubled to 12.6 billion won, and operating profit was 2.2 billion won. Analyst Yang analyzed that external growth was initiated through increased medical robot sales, and that the rise in revenue led directly to improved profitability, resulting in a turnaround to a profit structure.

This content was produced with the assistance of AI translation services.